Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 7, 2007, Pages 864-872

  Seuter, Sabine ^a,b,c   Väisänen, Sami ^b   Rådmark, Olof ^d   Carlberg, Carsten ^b,c   Steinhilber, Dieter ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 LO; Chromatin; In silico screening; VDR; Vitamin D response elements

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CALCITRIOL; COMPLEMENTARY DNA; LEUKOTRIENE; LUCIFERASE; PHOSPHORUS 32; RETINOID X RECEPTOR; RNA; RNA POLYMERASE II; VITAMIN D RECEPTOR;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; DNA PROTEIN COMPLEX; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TRANSCRIPTION REGULATION; VITAMIN D RESPONSIVE ELEMENT;

ARACHIDONATE 5-LIPOXYGENASE; BASE SEQUENCE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATIN; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOME, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, CALCITRIOL; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; VITAMIN D; VITAMIN D RESPONSE ELEMENT;

EID: 34250169427     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.04.007     Document Type: Article

References (48)

1. Samuelsson B., Dahlén S.-E., Lindgren J.-Å., Rouzer C.A., and Serhan C.N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237 (1987) 1171-1176
2. Lewis R.A., Austen K.F., and Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323 (1990) 645-655
3. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., Samani N.J., Gudmundsson G., Grant S.F., Thorgeirsson G., Sveinbjornsdottir S., Valdimarsson E.M., Matthiasson S.E., Johannsson H., Gudmundsdottir O., Gurney M.E., Sainz J., Thorhallsdottir M., Andresdottir M., Frigge M.L., Topol E.J., Kong A., Gudnason V., Hakonarson H., Gulcher J.R., and Stefansson K. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36 (2004) 233-239
4. Lockwood S.F., Penn M.S., Hazen S.L., Bikadi Z., and Zsila F. The effects of oral Cardaxtrade mark (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on 5-lipoxygenase in vitro and in vivo. Life Sci. (2006)
5. Manev H., Uz T., Sugaya K., and Qu T. Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 14 (2000) 1464-1469
6. Mehrabian M., and Allayee H. 5-lipoxygenase and atherosclerosis. Curr. Opin. Lipidol. 14 (2003) 447-457
7. Mehrabian M., Allayee H., Stockton J., Lum P.Y., Drake T.A., Castellani L.W., Suh M., Armour C., Edwards S., Lamb J., Lusis A.J., and Schadt E.E. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat. Genet. 37 (2005) 1224-1233
8. Steinhilber D. 5-Lipoxygenase: a target for antiinflammatory drugs revisited. Curr. Med. Chem. 6 (1999) 71-85
9. 3, retinoic acid, DMSO and TGF β. Biochem. Biophys. Res. Commun. 205 (1994) 1572-1580
10. 3. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 107-111
11. Härle D., Rådmark O., Samuelsson B., and Steinhilber D. Calcitriol and transforming growth factor-beta upregulate 5-lipoxygenase mRNA expression by increasing gene transcription and mRNA maturation. Eur. J. Biochem. 254 (1998) 275-281
12. 3. Adv. Exp. Med. Biol. 469 (1999) 105-111
13. Uhl J., Klan N., Rose M., Entian K.D., Werz O., and Steinhilber D. The 5-lipoxygenase promoter is regulated by DNA methylation. J. Biol. Chem. 277 (2002) 4374-4379
14. Sorg B.L., Klan N., Seuter S., Dishart D., Radmark O., Habenicht A., Carlberg C., Werz O., and Steinhilber D. Analysis of the 5-lipoxygenase promoter and characterization of a vitamin D receptor binding site. Biochim. Biophys. Acta 1761 (2006) 686-697
15. Seuter S., Sorg B.L., and Steinhilber D. The coding sequence mediates induction of 5-lipoxygenase expression by Smads3/4. Biochem. Biophys. Res. Commun. 348 (2006) 1403-1410
16. Sutton A.L., and MacDonald P.N. Vitamin D: more than a "bone-a-fide" hormone. Mol. Endocrinol. 17 (2003) 777-791
17. 3 and its analogs on growth control and tumorigenesis. Front. Biosci. 6 (2001) D820-D848
18. Jones G., Strugnell S.A., and DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 78 (1998) 1193-1231
19. 3. Crit. Rev. Eukaryot. Gene Expr. 8 (1998) 19-42
20. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L.J., Grippo J.F., and Hunziker W. Two nuclear signalling pathways for vitamin D. Nature 361 (1993) 657-660
21. Quack M., and Carlberg C. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J. Mol. Biol. 296 (2000) 743-756
22. 3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell. Biol. 15 (1995) 1154-1161
23. 3R receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature 370 (1994) 382-386
24. Leo C., and Chen J.D. The SRC family of nuclear receptor coactivators. Gene 245 (2000) 1-11
25. Fondell J.D., Guermah M., Malik S., and Roeder R.G. Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1959-1964
26. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Näär A.M., Erdjument-Bromage H., Tempst P., and Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398 (1999) 824-828
27. 3 receptor. Nucleic Acids Res. 34 (2006) 543-554
28. 3 target genes. Mol. Endocrinol. 19 (2005) 2685-2695
29. Dishart D., Schnur N., Klan N., Werz O., Steinhilber D., Samuelsson B., and Rådmark O. GC-rich sequences in the 5-lipoxygenase gene promoter are required for expression in Mono Mac 6 cells, characterization of a novel Sp1 binding site. Biochim. Biophys. Acta 1738 (2005) 37-47
30. 3. J. Mol. Biol. 350 (2005) 65-77
31. Toell A., Polly P., and Carlberg C. All natural DR3-type vitamin D response elements show a similar functionality in vitro. Biochem. J. 352 (2000) 301-309
32. 3 receptor binding site found in the rat atrial natriuretic factor promoter. Biochem. Biophys. Res. Commun. 218 (1996) 882-886
33. 3-responsive regions in its promoter. Nucleic Acids Res. 33 (2005) 2440-2451
34. Swami S., Raghavachari N., Muller U.R., Bao Y.P., and Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res. Treat. 80 (2003) 49-62
35. 3 in human colon cancer cells. Cancer Res. 63 (2003) 7799-7806
36. Klan N., and Steinhilber D. Transient transfection of the human myeloid cell line Mono Mac 6 using electroporation. Biotechniques 34 (2003) 142-147
37. Wasserman W.W., and Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat. Rev., Genet. 5 (2004) 276-287
38. 3. Nucleic Acids Res. 33 (2005) 5521-5532
39. Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., Lander E.S., and Kellis M. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434 (2005) 338-345
40. Ogata K., Sato K., and Tahirov T.H. Eukaryotic transcriptional regulatory complexes: cooperativity from near and afar. Curr. Opin. Struck. Biol. 13 (2003) 40-48
41. 3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J. Biol. Chem. 278 (2003) 48030-48040
42. Zhang C., Dowd D.R., Staal A., Gu C., Lian J.B., van Wijnen A.J., Stein G.S., and MacDonald P.N. Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. J. Biol. Chem. 278 (2003) 35325-35336
43. 3 receptor-corepressor partnership. FASEB J. 14 (2000) 1455-1463
44. 3 alters the transforming growth factor beta signaling pathway in renal tissue. J. Surg. Res. 100 (2001) 171-175
45. 3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements. J. Biol. Chem. 276 (2001) 15741-15746
46. Yanagi Y., Suzawa M., Kawabata M., Miyazono K., Yanagisawa J., and Kato S. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J. Biol. Chem. 274 (1999) 12971-12974
47. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., Toriyabe T., Kawabata M., Miyazono K., and Kato S. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283 (1999) 1317-1321
48. 3 analog-induced growth inhibition in breast cells. J. Cell. Physiol. 188 (2001) 383-393